Solu Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Solu Therapeutics is a clinical-stage biotechnology company based in Boston, founded in 2023. The company focuses on developing innovative therapeutics aimed at eliminating disease-driving cells in cancer, immunology, and autoimmunity. It operates with proprietary platforms, including CyTAC (Cytotoxicity Targeting Chimera) and TicTAC (Therapeutic Index Control Targeting Chimera), which enable the targeting of challenging cell surface proteins.
The lead clinical candidate, STX-0712, targets CCR2, a receptor involved in cancer progression, and is currently in Phase 1 clinical trials. Additional programs in development include a novel mast cell depletor for immunological diseases. The company has raised significant funding, including a $41 million Series A round, and actively seeks collaborations to enhance its development efforts. The leadership team comprises experienced professionals in biotechnology and drug development.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxxxx | $25593 | 107 | Private | - | 4468 | xxxxxxxxxx |
| xxxxxxxxxx | $63605 | 1 | Private | - | 7077 | x |
| xxxxxx | $22815 | 15 | Private | - | 6214 | xx |
| xxxx | $38709 | 22 | Private | - | 8494 | xx |
| xxxxxx | $69308 | 41 | Private | - | 2970 | xxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.